NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹638 Cr | ₹486 Cr | ₹606 Cr | ₹604 Cr | ₹1,030 Cr |
What is the latest Short Term Loans and Advances ratio of NATCO PHARMA ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹638 Cr |
Mar2023 | ₹486 Cr |
Mar2022 | ₹606 Cr |
Mar2021 | ₹604 Cr |
Mar2020 | ₹1,030 Cr |
How is Short Term Loans and Advances of NATCO PHARMA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹638 Cr | 31.43 | |
Mar2023 | ₹486 Cr | -19.89 | |
Mar2022 | ₹606 Cr | 0.41 | |
Mar2021 | ₹604 Cr | -41.39 | |
Mar2020 | ₹1,030 Cr | - |
Compare Short Term Loans and Advances of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹22,197.7 Cr | 2.2% | -14.3% | 47.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 2.2% |
-14.3% |
47.1% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses